SWG Grant-funded projects, 2026

From August to October, 2025, SWGs were invited to develop project ideas and apply for a 2026 SWG Grant.

For the 2026 call, EHA offered five grants, each worth €30,000.

Applications

We received 25 different applications from nine SWGs. This was ten more applications than we received in 2024 and fourteen more than in 2023.

These applications came from the:

  • SWG on Adult Acute Lymphoblastic Leukemia (ALL) (1 application)
  • SWG on Aging in Hematology (1 application)
  • SWG on Chronic Myeloid Leukemia (CML) (1 application)
  • SWG on European Research Initiative on CLL (ERIC) (1 application)
  • SWG on Immune Therapies for Hematologic Disorders (2 applications)
  • SWG on Infections in Hematology (1 application)
  • SWG on Myelodysplastic Syndromes (MDS) (7 applications)
  • SWG on Myelodysplastic Syndromes (MDS) and Red Cells and Iron Joint Application (1 application)
  • SWG on Myeloproliferative Neoplasms (MPN) (3 applications)
  • SWG on Quality of Life and Symptoms (QLS) (1 application)
  • SWG on Red Cells and Iron (3 applications)
  • SWG on Thrombocytopenias and Platelet Function Disorders (TPFD) (2 applications)
  • SWG on Transfusion and Bleeding & Thrombosis Joint Application (1 application)

Winners

All applications were reviewed against our selection criteria by SWG Committee members. These criteria are explained on the main SWG Grants page.

After careful consideration and fruitful discussion, the SWG Committee chose the following winners:

Share